摘要
In the past few years,immunotherapy has been integrated as part of routine cancer care.Agents targeting immune checkpoints have been proven to be effective against multiple types of cancer,including head and neck cancer and melanoma[1,2],and they continue to make headway in the treatment of other types of cancer[3,4].
出处
《镜湖医学》
2022年第1期72-73,共2页
MEDICAL JOURNAL OF KIANG WU